DaVita Inc.
DVA Healthcare Medical Care Facilities
DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow DVA
DaVita Inc. (DVA) EV/Sales
As of 16 October 2026, DaVita Inc. (DVA) trades at a EV/Sales of 1.6×. Over the past ten years it has ranged from 1.2× (October 2023) to 2.8× (December 2017); the current reading is higher than 35% of that period. That is above the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.3× | (19.80%) |
| FY2024 | 1.7× | 14.12% |
| FY2023 | 1.5× | 8.95% |
| FY2022 | 1.3× | (23.76%) |
| FY2021 | 1.7× | (6.69%) |
| FY2020 | 1.9× | 16.02% |
| FY2019 | 1.6× | (0.35%) |
| FY2018 | 1.6× | (21.59%) |
| FY2017 | 2.1× | 4.10% |
| FY2016 | 2.0× | (9.93%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.7× | 18.86% |
| Mar 2026 | 1.5× | 10.57% |
| Dec 2025 | 1.3× | (7.14%) |
| Sep 2025 | 1.4× | (7.49%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | 0.8× |
| UHS Universal Health Services, Inc. compare | 0.9× |
| PACS PACS Group, Inc. compare | 1.4× |
| THC Tenet Healthcare Corporation compare | 1.5× |
| DVA DaVita Inc. | 1.6× |
| ENSG The Ensign Group, Inc. compare | 1.8× |
| EHC Encompass Health Corporation compare | 2.4× |
| CHE Chemed Corporation compare | 2.6× |
| CON Concentra Group Holdings Parent, Inc. compare | 2.7× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on DVA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement